As of Aug 31
| -0.74 / -5.68%|
The 5 analysts offering 12-month price forecasts for TG Therapeutics Inc have a median target of 26.00, with a high estimate of 33.00 and a low estimate of 22.00. The median estimate represents a +111.73% increase from the last price of 12.28.
The current consensus among 5 polled investment analysts is to Buy stock in TG Therapeutics Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.